Loading...

ALK-Abelló A/S

AKBLF•PNK
Healthcare
Biotechnology
$35.55
$0.00(0.00%)
U.S. Market opens in 2h 8m

ALK-Abelló A/S (AKBLF) Stock Overview

Explore ALK-Abelló A/S’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.2B
P/E Ratio42.14
EPS (TTM)$0.85
ROE0.20%
Fundamental Analysis

AI Price Forecasts

1 Month$35.17
3 Months$44.50
1 Year Target$43.73

AKBLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ALK-Abelló A/S (AKBLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 81.82, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $43.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 42.14 and a market capitalization of 7.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
0.01%
1-Month Change
10.52%
3-Month Change
-1.51%
6-Month Change
7.74%
Year-to-Date (YTD) Change
-1.51%
1-Year Change
37.010%
3-Year Change
194.81%
5-Year Change
86.15%
All-Time (Max) Change
659.70%

Contact Information

https://www.alk.net
45 45 74 75 76
Boge Alle 6-8, Horsholm, NaN, 2970

Company Facts

2,736 Employees
IPO DateNov 16, 2009
CountryDK
Actively Trading

Frequently Asked Questions